MedTrace Logo

Psychedelic Virtual Reality

NCT06581263 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-03-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate a novel VRP.

Conditions

  • Psychedelic Experiences
  • Virtual Reality
  • Healthy Volunteer

Interventions

DEVICE

Meta Quest 3

Meta Quest 3 is a virtual reality headset device

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Anahita Bassir Nia, MD · Yale University

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-22
Primary Completion
2026-03-22
Completion
2026-03-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06581263 on ClinicalTrials.gov